Health data research in the UK is rapidly evolving, with new capabilities emerging through the rise of hybrid engagement and the accelerated adoption of digital technologies.
COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement.
A herculean national effort has seen 69% of paused studies due to COVID restarted under the National Institute for Health Research’s (NIHR) Restart Framework.